Integral Diagnostics

Integral Diagnostics Market Cap per Employee

The Market Cap per Employee of Integral Diagnostics (IDX.AX) as of Nov 5, 2026 is 478,859.96 AUD. In the previous year, Market Cap per Employee was 478,859.96 AUD — a change of 0.00% (lower).

Market Cap per Employee

478,859.96AUD

YoY

0.00%

Last updated:

Market Cap per Employee of Integral Diagnostics is 2026 478,859.96 AUD. Market Cap per Employee of Integral Diagnostics was 2025 478,859.96 AUD. It decreases by 0.00% lower compared to the previous year.

The Integral Diagnostics Market Cap per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Cap per Employee
Date
Market Cap per Employee
Jan 1, 2019
478,859.96 AUD
Jan 1, 2020
478,859.96 AUD
Jan 1, 2021
478,859.96 AUD
Jan 1, 2022
478,859.96 AUD
Jan 1, 2023
478,859.96 AUD
Jan 1, 2024
478,859.96 AUD
Jan 1, 2025
478,859.96 AUD
Jan 1, 2026
478,859.96 AUD
The Integral Diagnostics Market Cap per Employee history
YEARMarket Cap per EmployeeYoY
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD0.00%
478,859.96AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Integral Diagnostics Stock analysis

What does Integral Diagnostics do? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Integral Diagnostics stock

Market Cap per Employee of Integral Diagnostics is 478,859.96 AUD in 2026.

Market Cap per Employee of Integral Diagnostics changed from 478,859.96 AUD to 478,859.96 AUD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Market Cap per Employee Integral Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Market cap per employee shows the market value attributed to each employee. Technology companies typically have higher values due to intellectual capital.

Market Cap per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Market Cap per Employee's Integral Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Integral Diagnostics

All Key Metrics — Integral Diagnostics